rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mark Reynolds

CFO

Company insider

Files Form 4 as: CFO, GeoVax Labs.

In numbers

Trades disclosed
41
Buys
14
Sells
0
Bought
$372K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
14 Mar 2007
Last trade
17 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
GOVX GeoVax LabsOfficer · Biotechnology · last 17 Jun 202614 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 22 Jun 2026GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—17,600 at $0.00filing
17 Jun 2026filed 22 Jun 2026GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—17,600 at $0.00filing
5 Jun 2025filed 6 Jun 2025GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
31 Mar 2025filed 31 Mar 2025GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$7,3446,800 at $1.08filing
12 Aug 2024filed 14 Aug 2024GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—15,700 at $0.00filing
7 Feb 2024filed 7 Feb 2024GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$5,5402,000 at $2.77filing
18 Aug 2023filed 21 Aug 2023GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$5,20010,000 at $0.52filing
1 Aug 2023filed 14 Aug 2023GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
20 Apr 2023filed 21 Apr 2023GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$5,0408,000 at $0.63filing
7 Dec 2021filed 8 Dec 2021GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—48,200 at $0.00filing
11 Aug 2021filed 11 Aug 2021GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—128,000 at $0.00filing
29 Sep 2020filed 29 Sep 2020GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code P—60,184 at $0.00filing
29 Sep 2020filed 29 Sep 2020GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$301K60,184 at $5.00filing
17 Dec 2018filed 19 Dec 2018GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—750,000 at $0.00filing
20 Dec 2017filed 22 Dec 2017GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—750,000 at $0.00filing
13 Dec 2016filed 15 Dec 2016GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—335,000 at $0.00filing
11 Dec 2015filed 14 Dec 2015GOVX GeoVax Labsoption or derivative · BiotechnologySEC FORM 4 Code A—60,000 at $0.00filing
23 Apr 2015filed 23 Apr 2015GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$1,80010,000 at $0.18filing
22 Apr 2015filed 23 Apr 2015GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$1,70010,000 at $0.17filing
22 Apr 2015filed 23 Apr 2015GOVX GeoVax LabsBiotechnologySEC FORM 4 Bought$1,70010,000 at $0.17filing

News

Lisata Therapeutics (NASDAQ:LSTA) & GeoVax Labs (NASDAQ:GOVX) Head to Head ContrastGOVX · dailypolitical.com · 8 Oct 2026

0 headlines in the last 90 days name Mark Reynolds; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care14

Buys in green, sells in red, by the company’s sector.

Related people

Robert T. McNallyDirector · Director at GeoVax Labs, filing Form 4 there in the last year
Randal D. ChaseDirector · Director at GeoVax Labs, filing Form 4 there in the last year
David A. DoddPresident, CEO · President, CEO at GeoVax Labs, filing Form 4 there in the last year
Mark J. NewmanChief Scientific Officer · Chief Scientific Officer at GeoVax Labs, filing Form 4 there in the last year
John N. Spencer Jr.Director · Director at GeoVax Labs, filing Form 4 there in the last year